A detailed history of Met Life Investment Management, LLC transactions in Conmed Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 17,636 shares of CNMD stock, worth $1.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,636
Previous 17,636 -0.0%
Holding current value
$1.27 Million
Previous $1.22 Million 3.76%
% of portfolio
0.01%
Previous 0.01%

Shares

53 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$61.9 - $80.36 $116,805 - $151,639
1,887 Added 11.98%
17,636 $1.22 Million
Q1 2024

May 14, 2024

BUY
$75.36 - $112.51 $1.19 Million - $1.77 Million
15,749 New
15,749 $1.26 Million
Q3 2023

May 09, 2024

BUY
$97.55 - $135.91 $81,551 - $113,620
836 Added 5.45%
16,163 $1.63 Million
Q2 2023

Apr 29, 2024

BUY
$102.55 - $136.38 $1.66 Million - $2.2 Million
16,163 New
16,163 $2.2 Million
Q2 2023

Aug 10, 2023

BUY
$102.55 - $136.38 $85,731 - $114,013
836 Added 5.45%
16,163 $2.2 Million
Q1 2023

May 09, 2024

BUY
$89.75 - $107.27 $1.38 Million - $1.64 Million
15,327 New
15,327 $1.59 Billion
Q3 2022

May 10, 2024

BUY
$77.78 - $103.92 $23,878 - $31,903
307 Added 2.04%
15,327 $1.23 Million
Q3 2022

Mar 22, 2023

BUY
$77.78 - $103.92 $23,878 - $31,903
307 Added 2.04%
15,327 $1.23 Million
Q3 2022

Nov 14, 2022

BUY
$77.78 - $103.92 $23,878 - $31,903
307 Added 2.04%
15,327 $1.23 Million
Q2 2022

May 10, 2024

SELL
$88.23 - $154.18 $32,556 - $56,892
-369 Reduced 2.4%
15,020 $1.44 Million
Q2 2022

Jun 20, 2023

SELL
$88.23 - $154.18 $27,086 - $47,333
-307 Reduced 2.0%
15,020 $1.44 Million
Q2 2022

Mar 22, 2023

SELL
$88.23 - $154.18 $32,556 - $56,892
-369 Reduced 2.4%
15,020 $1.44 Million
Q2 2022

Aug 11, 2022

SELL
$88.23 - $154.18 $32,556 - $56,892
-369 Reduced 2.4%
15,020 $1.44 Million
Q1 2022

May 10, 2024

BUY
$121.88 - $150.0 $1.88 Million - $2.31 Million
15,389 New
15,389 $2.29 Million
Q1 2022

Jun 20, 2023

BUY
$121.88 - $150.0 $7,556 - $9,300
62 Added 0.4%
15,389 $2.29 Million
Q1 2022

Mar 22, 2023

BUY
$121.88 - $150.0 $673,021 - $828,300
5,522 Added 55.96%
15,389 $2.29 Million
Q1 2022

May 12, 2022

BUY
$121.88 - $150.0 $673,021 - $828,300
5,522 Added 55.96%
15,389 $2.29 Million
Q4 2021

May 17, 2024

SELL
$129.86 - $157.03 $76,617 - $92,647
-590 Reduced 5.64%
9,867 $1.4 Million
Q4 2021

Jun 21, 2023

SELL
$129.86 - $157.03 $709,035 - $857,383
-5,460 Reduced 35.62%
9,867 $1.4 Million
Q4 2021

Mar 22, 2023

SELL
$129.86 - $157.03 $76,617 - $92,647
-590 Reduced 5.64%
9,867 $1.4 Million
Q4 2021

Feb 15, 2022

SELL
$129.86 - $157.03 $76,617 - $92,647
-590 Reduced 5.64%
9,867 $1.4 Million
Q3 2021

Jun 21, 2023

SELL
$122.87 - $139.12 $598,376 - $677,514
-4,870 Reduced 31.77%
10,457 $1.37 Million
Q2 2021

Jun 21, 2023

SELL
$128.08 - $145.09 $623,749 - $706,588
-4,870 Reduced 31.77%
10,457 $1.44 Million
Q1 2021

May 17, 2024

SELL
$111.35 - $130.59 $589,264 - $691,082
-5,292 Reduced 33.6%
10,457 $1.37 Million
Q1 2021

Jun 26, 2023

SELL
$111.35 - $130.59 $542,274 - $635,973
-4,870 Reduced 31.77%
10,457 $1.37 Billion
Q1 2021

Mar 22, 2023

SELL
$111.35 - $130.59 $103,889 - $121,840
-933 Reduced 8.19%
10,457 $1.37 Million
Q1 2021

May 14, 2021

SELL
$111.35 - $130.59 $103,889 - $121,840
-933 Reduced 8.19%
10,457 $1.37 Million
Q4 2020

Jun 22, 2023

SELL
$77.7 - $112.82 $305,904 - $444,172
-3,937 Reduced 25.69%
11,390 $1.28 Million
Q3 2020

May 24, 2024

SELL
$69.87 - $89.2 $74,271 - $94,819
-1,063 Reduced 8.54%
11,390 $896 Million
Q3 2020

Jun 26, 2023

SELL
$69.87 - $89.2 $275,078 - $351,180
-3,937 Reduced 25.69%
11,390 $896,000
Q3 2020

Mar 22, 2023

SELL
$69.87 - $89.2 $74,271 - $94,819
-1,063 Reduced 8.54%
11,390 $896,000
Q3 2020

Nov 13, 2020

SELL
$69.87 - $89.2 $74,271 - $94,819
-1,063 Reduced 8.54%
11,390 $896,000
Q2 2020

May 24, 2024

SELL
$50.31 - $81.76 $165,821 - $269,480
-3,296 Reduced 20.93%
12,453 $896 Million
Q2 2020

Jun 26, 2023

SELL
$50.31 - $81.76 $144,590 - $234,978
-2,874 Reduced 18.75%
12,453 $896,000
Q2 2020

Mar 22, 2023

BUY
$50.31 - $81.76 $52,976 - $86,093
1,053 Added 9.24%
12,453 $896,000
Q2 2020

Aug 14, 2020

BUY
$50.31 - $81.76 $52,976 - $86,093
1,053 Added 9.24%
12,453 $896,000
Q1 2020

Jul 12, 2023

SELL
$39.81 - $112.01 $156,333 - $439,863
-3,927 Reduced 25.62%
11,400 $652,000
Q4 2019

Jul 12, 2023

SELL
$93.31 - $116.55 $366,428 - $457,691
-3,927 Reduced 25.62%
11,400 $1.27 Million
Q4 2019

Mar 22, 2023

SELL
$93.31 - $116.55 $82,765 - $103,379
-887 Reduced 7.22%
11,400 $1.27 Million
Q4 2019

Feb 14, 2020

SELL
$93.31 - $116.55 $82,765 - $103,379
-887 Reduced 7.22%
11,400 $1.28 Million
Q3 2019

Jul 12, 2023

SELL
$83.97 - $102.19 $255,268 - $310,657
-3,040 Reduced 19.83%
12,287 $1.18 Million
Q3 2019

Mar 22, 2023

BUY
$83.97 - $102.19 $50,717 - $61,722
604 Added 5.17%
12,287 $1.18 Million
Q3 2019

Nov 14, 2019

BUY
$83.97 - $102.19 $50,717 - $61,722
604 Added 5.17%
12,287 $1.18 Million
Q2 2019

Jul 12, 2023

SELL
$78.27 - $86.94 $237,940 - $264,297
-3,040 Reduced 19.83%
12,287 $1.05 Million
Q1 2019

Jul 13, 2023

SELL
$60.79 - $83.18 $221,518 - $303,107
-3,644 Reduced 23.78%
11,683 $971,000
Q4 2018

Jul 13, 2023

SELL
$57.41 - $79.06 $209,202 - $288,094
-3,644 Reduced 23.78%
11,683 $750,000
Q4 2018

Mar 22, 2023

SELL
$57.41 - $79.06 $395,267 - $544,328
-6,885 Reduced 37.08%
11,683 $750,000
Q4 2018

Feb 14, 2019

SELL
$57.41 - $79.06 $395,267 - $544,328
-6,885 Reduced 37.08%
11,683 $750,000
Q3 2018

Jul 13, 2023

SELL
$73.09 - $81.64 $266,339 - $297,496
-3,644 Reduced 23.78%
11,683 $925,000
Q3 2018

Mar 22, 2023

BUY
$73.09 - $81.64 $236,884 - $264,595
3,241 Added 21.15%
18,568 $1.47 Million
Q3 2018

Nov 14, 2018

BUY
$73.09 - $81.64 $503,224 - $562,091
6,885 Added 58.93%
18,568 $1.47 Million
Q2 2018

Aug 15, 2018

SELL
$61.34 - $76.43 $103,541 - $129,013
-1,688 Reduced 12.62%
11,683 $855,000
Q4 2017

Feb 15, 2018

BUY
$49.3 - $54.24 $659,190 - $725,243
13,371
13,371 $682,000

Others Institutions Holding CNMD

About CONMED Corp


  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $2.2B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.